xellia Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- xellia Pharmaceuticals's estimated annual revenue is currently $329.8M per year.
- xellia Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- xellia Pharmaceuticals has 1641 Employees.
- xellia Pharmaceuticals grew their employee count by 0% last year.
xellia Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | Global Serialization Process Owner | Reveal Email/Phone |
2 | Senior Manager - Global CMO Planning and Logistics | Reveal Email/Phone |
3 | Inventory and CMO Controller | Reveal Email/Phone |
4 | VP, U.S. General Counsel | Reveal Email/Phone |
5 | VP Manufacturing Operations North America | Reveal Email/Phone |
6 | Head Production Planner, FDF | Reveal Email/Phone |
7 | VP, Manufacturing Operations North America | Reveal Email/Phone |
8 | VP Manufacturing International | Reveal Email/Phone |
9 | Controller Accounts Payable | Reveal Email/Phone |
10 | Head Global Engineering | Reveal Email/Phone |
xellia Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $706.3M | 3514 | 6% | N/A | N/A |
What Is xellia Pharmaceuticals?
Xellia is a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. Our anti-infective treatments are generics that combat serious bacterial and antibiotic resistant infections as well as certain fungal diseases
keywords:N/AN/A
Total Funding
1641
Number of Employees
$329.8M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
xellia Pharmaceuticals News
2022-04-19 - Brown-Sequard Syndrome Market 2022 Development Status ...
... Aurobindo Pharma Limited, Fresenius Kabi Canada, Hikma, AdvaCare Pharma, SteriMax, Baxter Healthcare, Stanex, Xellia Pharmaceuticals,...
2022-04-17 - MRSA Antibiotic Preparations Market 2022 Development ...
... Merck, Fresenius Kabi, Xellia Pharmaceuticals (Novo Holdings), ... Zhejiang Hisun Pharmaceutical, North China Pharmaceutical.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $724.6M | 2887 | 8% | N/A |
#2 | $2371.9M | 5278 | -2% | N/A |